Abstract:One of the major applications of generative models for drug discovery targets the lead-optimization phase. During the optimization of a lead series, it is common to have scaffold constraints imposed on the structure of the molecules designed. Without enforcing such constraints, the probability of generating molecules with the required scaffold is extremely low and hinders the practicality of generative models for de novo drug design. To tackle this issue, we introduce a new algorithm, named SAMOA (Scaffold Constrained Molecular Generation), to perform scaffold-constrained in silico molecular design. We build on the well-known SMILES-based Recurrent Neural Network (RNN) generative model, with a modified sampling procedure to achieve scaffold-constrained generation. We directly benefit from the associated reinforcement learning methods, allowing to design molecules optimized for different properties while exploring only the relevant chemical space. We showcase the method's ability to perform scaffold-constrained generation on various tasks: designing novel molecules around scaffolds extracted from SureChEMBL chemical series, generating novel active molecules on the Dopamine Receptor D2 (DRD2) target, and finally, designing predicted actives on the MMP-12 series, an industrial lead-optimization project.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.jcim.0c01015?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.jcim.0c01015</a>.Availability of data used to train models and run experiments, algorithmic description of naive policy masking (Algorithm S1), algorithmic description of hill-climbing (Algorithm S2), examples of molecules obtained after sampling the core of fexofenadine (Figure S1 for sampled molecules, Figure S2 for the original molecule), examples of molecules obtained after replacing the ring system of fexofenadine (Figure S3), distributions of ClogP, Molecular Weight, QED and SAS for reference molecules, molecules where a branched decoration was sampled, and molecules where the core was sampled (Figure S4), the 17 validation scaffolds from SureChEMBL (Figure S5), histograms of Tanimoto similarities between generated molecules for each of the DRD2 scaffolds (Figure S6), and unicity of sampled decorations for each open positions of the DRD2 scaffolds (Figure S7) (<a class="ext-link" href="/doi/suppl/10.1021/acs.jcim.0c01015/suppl_file/ci0c01015_si_001.pdf">PDF</a>)This article has not yet been cited by other publications.

DeLA-DrugSelf: Empowering multi-objective de novo design through SELFIES molecular representation

DeLA-Drug: A Deep Learning Algorithm for Automated Design of Druglike Analogues

Streamlining Computational Fragment-Based Drug Discovery Through Evolutionary Optimization Informed by Ligand-Based Virtual Prescreening

Optimized Drug Design using Multi-Objective Evolutionary Algorithms with SELFIES

DrugSynthMC: an atom based generation of drug-like molecules with Monte Carlo Search

A deep-learning view of chemical space designed to facilitate drug discovery

LEADD: Lamarckian evolutionary algorithm for de novo drug design

Guided Multi-objective Generative AI to Enhance Structure-based Drug Design

DrugEx: Deep Learning Models and Tools for Exploration of Drug-Like Chemical Space

De novo drug design by iterative multiobjective deep reinforcement learning with graph-based molecular quality assessment

MolDesigner: Interactive Design of Efficacious Drugs with Deep Learning

DrugEx V2: De Novo Design of Drug Molecules by Pareto-based Multi-Objective Reinforcement Learning in Polypharmacology

Multi-Objective De Novo Drug Design with Conditional Graph Generative Model

REINVENT 2.0: An AI Tool for De Novo Drug Design

De Novo Drug Design by Multi-Objective Path Consistency Learning with Beam A∗ Search

Scaffold-Constrained Molecular Generation

Human-in-the-loop assisted de novo molecular design

Genetic Algorithm-Based Receptor Ligand: A Genetic Algorithm-Guided Generative Model to Boost the Novelty and Drug-Likeness of Molecules in a Sampling Chemical Space.

Deep Generative Design with 3D Pharmacophoric Constraints

Assessing Methods and Obstacles in Chemical Space Exploration

Molecular generation strategy and optimization based on A2C reinforcement learning in de novo drug design